News | April 16, 2014

Covidien Implements Voluntary Recall of its Pipeline Embolization Device and Alligator Retrieval Device

April 16, 2014 — Covidien announced it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline embolization device and Alligator retrieval device, where the polytetrafluoroethylene (PTFE) coating applied to the delivery wire could delaminate and detach from the devices.

PTFE coating is used to reduce friction between devices and ease navigation through the vasculature. Delamination of the PTFE coating could potentially lead to embolic occlusion in the cerebral vasculature with the risk of stroke and/or death.

Covidien learned of this issue through internal product testing. The company has not received any reports of patient injuries to date related to this issue.

The Pipeline embolization device is indicated for the endovascular treatment of adults (22 years of age and older) with large or giant wide?necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments. The Alligator retrieval device is intended for use in the peripheral and neuro?vasculature for foreign body retrieval.

A total of 32 Pipeline embolization devices and 621 Alligator retrieval devices are affected by this recall. The products were manufactured and distributed from May 2013 to March 2014. This issue involves both the Pipeline embolization device sold in the United States, Australia, France, Germany and United Kingdom, and the Alligator retrieval device sold in the United States, Australia, Canada, Europe and Latin America.

Covidien alerted customers to the recall by letter on April 1, 2014, and is arranging for replacement of the recalled products. The U.S. Food and Drug Administration (FDA) and other regulatory bodies also have been notified.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

For more information: www.covidien.com

Related Content

News | Stroke

September 7, 2021 — Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke ...

Home September 07, 2021
Home
News | Stroke

July 7, 2021 – Robocath, a company that designs, develops and commercializes cath lab robotic solutions to treat ...

Home July 07, 2021
Home
News | Stroke

April 7, 2021 — Market research firm GlobalData's new report, Neurovascular Thrombectomy Devices (Neurology Devices) ...

Home April 07, 2021
Home
News | Stroke

December 1, 2020 – Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA ...

Home December 01, 2020
Home
News | Stroke

July 9, 2020 — The Society for Vascular Surgery (SVS) has released a clinical competence statement on training and ...

Home July 09, 2020
Home
News | Stroke

February 20, 2020 — Synaptive Medical, a leader in robotic surgical visualization, announced today the company has ...

Home February 20, 2020
Home
News | Stroke

October 18, 2019 — An algorithm developed by faculty at The University of Texas Health Science Center at Houston ...

Home October 18, 2019
Home
News | Stroke

August 16, 2019 — Every second counts for stroke patients, as studies show they can lose up to 27 million brain cells ...

Home August 16, 2019
Home
Technology | Stroke

May 21, 2019 – Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin ...

Home May 21, 2019
Home
Feature | Stroke | Inga Shugalo

With its increasing role in medical imaging, artificial intelligence (AI) gradually is becoming a go-to technology for ...

Home May 17, 2019
Home
Subscribe Now